Mineralys Therapeutics (MLYS) Stock Chart & Stock Price History $14.21 +0.27 (+1.94%) As of 04:00 PM Eastern Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Mineralys Therapeutics Stock Price Performance 5 Day Performance+5.89%1 Month Performance-3.64%3 Month Performance+37.55%6 Month Performance+2.51%Year-To-Date Performance+14.75%1 Year Performance+15.31% Receive MLYS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Mineralys Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address MLYS Stock Chart for Wednesday, April, 30, 2025 MLYS Chart by TradingView Mineralys Therapeutics Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/29/2025$13.56$13.94+2.80%$13.96$13.06458,472 shs$904.37 million04/28/2025$13.34$13.56+1.65%$14.11$13.20582,659 shs$879.72 million04/25/2025$14.09$13.34-5.32%$13.97$12.90822,303 shs$865.45 million04/24/2025$13.53$14.09+4.14%$14.16$13.38394,554 shs$914.10 million04/23/2025$13.21$13.53+2.42%$14.14$13.40536,140 shs$877.77 million04/22/2025$13.24$13.21-0.23%$13.63$12.94502,748 shs$857.01 million04/21/2025$13.35$13.24-0.82%$13.67$12.77638,842 shs$858.96 million04/18/2025$13.35$13.35$13.87$12.90382,306 shs$866.10 million04/17/2025$13.50$13.35-1.11%$13.87$12.90382,306 shs$838.18 million04/16/2025$13.88$13.50-2.74%$13.87$13.10477,997 shs$847.60 million Get the Latest News and Ratings for MLYS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Mineralys Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 04/15/2025$13.92$13.88-0.29%$14.43$13.77440,438 shs$871.46 million04/14/2025$13.40$13.92+3.88%$14.83$13.47812,076 shs$873.97 million04/11/2025$12.19$13.40+9.93%$13.53$11.77848,809 shs$841.32 million04/10/2025$12.83$12.19-4.99%$12.46$11.481.01 million shs$765.35 million04/09/2025$11.77$12.83+9.01%$12.84$10.442.29 million shs$805.53 million04/09/2025$11.77$12.83+9.01%$12.84$10.442.29 million shs$805.53 million04/08/2025$12.05$11.77-2.32%$12.75$11.391.73 million shs$738.98 million04/08/2025$12.05$11.77-2.32%$12.75$11.391.73 million shs$738.98 million04/07/2025$12.40$12.05-2.82%$12.47$11.031.27 million shs$756.56 million04/04/2025$13.53$12.40-8.35%$13.49$12.051.58 million shs$778.53 million04/03/2025$14.00$13.53-3.36%$14.03$13.131.11 million shs$849.48 million04/02/2025$13.84$14.00+1.16%$14.24$13.001.44 million shs$878.99 million04/01/2025$15.88$13.84-12.85%$17.17$13.582.33 million shs$868.94 million03/31/2025$14.66$15.88+8.32%$16.02$14.062.15 million shs$997.03 million Related Companies SWTX Stock Chart OGN Stock Chart MRUS Stock Chart CRNX Stock Chart SRRK Stock Chart AKRO Stock Chart VKTX Stock Chart XENE Stock Chart CPRX Stock Chart MOR Stock Chart Receive MLYS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Mineralys Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:MLYS) was last updated on 4/30/2025 by MarketBeat.com Staff From Our PartnersTrump Orders 'National Digital Asset Stockpile'‘Digital Asset Reserve’ for THIS Coin??? Get all the details before this story gains even more tractionCrypto 101 Media | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredM.A.G.A. is Finished – This Could be even BetterYou’ve no doubt heard Trump’s rally cry: Make America Great Again. But recently the President made a big ch...Paradigm Press | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe July 23rd Crypto Trigger Could Mark the Beginning of Bitcoin’s Next Big Move Bitcoin’s early 2024 ETF r...Crypto Swap Profits | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredElon Musk’s next move from the Oval Office?No one is closer to President Trump than Tesla CEO Elon Musk. He's been dubbed Trump's "first buddy." Tr...Weiss Ratings | SponsoredChina’s next move could destroy U.S. techThe U.S. fired the first shot with 145% tariffs. Apple relies heavily on Chinese production. Tesla needs Ch...Investors Alley | SponsoredThis isn’t a trade war. It’s worse…Investigative Journalist Bombhsell: The Curse on the U.S Dollar Depleted retirement accounts? Meme coin inv...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mineralys Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Mineralys Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy MLYS Stock Free MLYS Stock Alerts